Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04869943
Title Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer (ARTEST)
Acronym ARTEST
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Veru Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ESP


No variant requirements are available.